Our Laboratories : more than 130 years of existence

Edouard Chaix and Ernest Maillet founded the company Maillet et Cie in 1888, based at 10, rue de l’Orne, in Paris (15th arrondissement).

Charles Rémy and Marie Bra join forces to form Chaix et Rémy. They specialise in the manufacture of liquid organ extracts.

Henri Chausse joins the company. He is in charge of the highly delicate preparation of an anti-streptococcal serum.

12 November : a presidential decree authorises the Chaix et Rémy company to produce and sell organic serums.

On the demise of Charles Rémy, Edouard Chaix goes into partnership with Marie Bra, then with Henri Chausse. Chaix et Cie markets flagship products such as Succomusculin.

Léon Cazin, company pharmacist since 1894, contributes to international development, in countries like Brazil.

Léon Cazin takes over from Edouard Chaix and initiates a company in his name. He then joins forces with Henri Hugon, also a pharmacist.

At auctions, Herni Hugon acquires the house at 8, rue de l’Orne, then the pharmaceutical premises at 10 rue de l’Orne.

Alice Mullot and her son Jean Hugon take over the company after the death of Henri Hugon in 1935. The corporate name becomes Laboratoires Chaix et du Marais – Hugon et Cie.

The Marais site is bombed during the war. The activity is therefore concentrated at 10, rue Alphonse Bertillon, formerly rue de l’Orne.

The site in rue Alphonse Bertillon is bought by the Chauffage Urbain de la Ville de Paris. Jean Hugon relocates production to Blois, at the corner of the Boulevard de l’Industrie and the Route de Vendôme. The head office remains in Paris.

Opening of the Chaussée-Saint-Victor plant. This establishment makes it possible to raise the production capacity and develop new activities.

The first Marketing Authorisations are obtained for glass bottle ampoules.

Discontinuation of marketing of the last MA presentations in double-tipped ampoules.

Continuing on from Brigitte Truelle-Hugon, Philippe Truelle, her son teams up with his two brothers, Jean-Marie and Olivier, to take over management of the business.

ISO 13485 certification obtained for Quality Management in the medical device industry.

Launch of a new high-volume bag-filling activity (Maxima®) on behalf of other pharmaceutical firms

Launch of the first phase of the industrial master plan aimed at increasing production capacities